|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09906 HONLIV HEALTH
Nominal 
2.230 -0.020 (-0.889%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 760,527 | 4.498% | 727,789 | 606,837 | 524,043 | 531,108 |
| Cost of Sales | (615,683) | 4.460% | (589,394) | (471,531) | (386,451) | (360,952) |
| Gross Profit | 144,844 | 4.660% | 138,395 | 135,306 | 137,592 | 170,156 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (15,294) | 679.114% | (1,963) | (85) | (4,610) | (25) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 51,422 | -18.405% | 63,021 | 50,542 | 30,853 | 68,479 | |
| Taxation | (12,724) | -6.975% | (13,678) | (13,524) | (8,662) | (18,621) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (388) | -2.020% | (396) | (403) | (351) | (496) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 38,310 | -21.732% | 48,947 | 36,615 | 21,840 | 49,362 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 6,023 | -- | (1,460) | 16,019 | 31,117 | 28,002 |
| Depreciation & Amortisation | 60,236 | 10.010% | 54,755 | 33,713 | 28,505 | 24,474 |
| Directors' Emoluments | 3,092 | 0.586% | 3,074 | 2,750 | 1,789 | 1,731 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 7.000 | -12.500% | 8.000 | 6.000 | 4.000 | 11.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.157 | -- | 0.200 | 0.152 | 0.143 | 0.192 |
| NBV per share ($) | 0.903 | -- | 0.916 | 0.936 | 0.875 | -- |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 20,042,000 |
| %Change | -17.397% |
| EPS / (LPS) | RMB 0.040 |
| NBV Per Share (¥) | RMB 0.936 |